Xiangbei Welman Pharmaceutical Co., Ltd   Report issue

For profit Phase 2 Phase 4
Founded: Guangzhou China (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2011
NCT01760109
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Xiangbei Welman Pharmaceutical Co., Ltd

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Gonorrhea (Phase 4)

Infections (Phase 4)

Respiratory Tract Infections (Phase 4)

Urinary Tract Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7